Vasoactive Intestinal Peptide Regulates its Receptor Expression and Functions of Human Keratinocytes via Type I Vasoactive Intestinal Peptide Receptors
- 1 May 2001
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 116 (5) , 743-749
- https://doi.org/10.1046/j.1523-1747.2001.01306.x
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 51 references indexed in Scilit:
- Neuropeptides and general neuronal marker in psoriasis an immunohistochemical studyClinical and Experimental Dermatology, 1995
- Neuropeptides in skinJournal of the American Academy of Dermatology, 1995
- Human Intestinal VIP Receptor: Cloning and Functional Expression of Two cDNA Encoding Proteins with Different N-Terminal DomainsBiochemical and Biophysical Research Communications, 1994
- The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptideFEBS Letters, 1993
- Vasoactive intestinal peptide downregulates the expression of IL-2 but not of IFNγ from stimulated murine T lymphocytesJournal of Neuroimmunology, 1993
- Cloning and Functional Expression of a Human Neuroendocrine Vasoactive Intestinal Peptide ReceptorBiochemical and Biophysical Research Communications, 1993
- Neuropeptides in skin disease: increased VIP in eczema and psoriasis but not axillary hyperhidrosisBritish Journal of Dermatology, 1991
- Skin levels of vasoactive intestinal polypeptide in atopic dermatitisArchives of Dermatological Research, 1991
- Multiple actions of interleukin 6 within a cytokine networkImmunology Today, 1988
- Interaction of vasoactive intestinal peptide (VIP) with human peripheral blood lymphocytes: Specific binding and cyclic AMP productionGeneral Pharmacology: The Vascular System, 1986